RA Capital Advisors
Overview
RA Capital Advisors is a boutique investment bank specializing in sell-side M&A advisory services, divestitures, and capital-raising for privately-held middle-market companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Jade Biosciences, Inc. | Aug 2020 | Series A | - |
| Freenome | Feb 2024 | VC Round | - |
| Sionna | Mar 2024 | Series C | - |
| SpyGlass Pharma | Jun 2025 | Series D | - |
| Acrivon Therapeutics | Nov 2021 | Series B | - |
For institutional investors. Book with your work email.
Key People
Jim Zehentbauer
Principal
reha sharma
Investor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is RA Capital Advisors based?
RA Capital Advisors is headquartered in San Diego, California, United States.
When was RA Capital Advisors founded?
RA Capital Advisors was founded in 1988.
How many portfolio companies does RA Capital Advisors have?
RA Capital Advisors has 8 portfolio companies in Caplight's dataset.
What are some companies in RA Capital Advisors's portfolio?
Portfolio companies visible on Caplight include Jade Biosciences, Inc., Freenome, Sionna, SpyGlass Pharma, Acrivon Therapeutics.
What was RA Capital Advisors's most recent investment shown here?
RA Capital Advisors's most recent investment in this portfolio sample was in SpyGlass Pharma in 2025.
What sectors does RA Capital Advisors focus on?
RA Capital Advisors focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does RA Capital Advisors focus on?
RA Capital Advisors typically invests at the MultiStage stage.
What is RA Capital Advisors's AUM?
RA Capital Advisors's assets under management are estimated between $10.0B and $100.0B.